谷歌浏览器插件
订阅小程序
在清言上使用

Genomic Copy Number Predicts Esophageal Cancer Years Before Transformation

Nature medicine(2020)

引用 76|浏览50
暂无评分
摘要
Longitudinal molecular profiling of copy number alterations in patients with Barrett's esophagus can identify patients at higher risk of developing esophageal cancer. Recent studies show that aneuploidy and driver gene mutations precede cancer diagnosis by many years(1-4). We assess whether these genomic signals can be used for early detection and pre-emptive cancer treatment using the neoplastic precursor lesion Barrett's esophagus as an exemplar(5). Shallow whole-genome sequencing of 777 biopsies, sampled from 88 patients in Barrett's esophagus surveillance over a period of up to 15 years, shows that genomic signals can distinguish progressive from stable disease even 10 years before histopathological transformation. These findings are validated on two independent cohorts of 76 and 248 patients. These methods are low-cost and applicable to standard clinical biopsy samples. Compared with current management guidelines based on histopathology and clinical presentation, genomic classification enables earlier treatment for high-risk patients as well as reduction of unnecessary treatment and monitoring for patients who are unlikely to develop cancer.
更多
查看译文
关键词
Cancer screening,Diagnostic markers,Biomedicine,general,Cancer Research,Metabolic Diseases,Infectious Diseases,Molecular Medicine,Neurosciences
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要